Valid Ghana · FDA Ghana

SCIRICA 75MG CAPSULES (Each capsule contains Pregabalim 75mg)

Pregabalim

FDA/SD.265-020198 Pregabalim 75mg

What it does

Pregabalin is a medication used to help manage nerve pain and certain types of seizures.

Commonly used for: nerve pain (neuropathic pain), epilepsy (seizures), generalized anxiety disorder

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.265-020198
Registration date
2026-02-24
Expiry date
2031-03-01
Status
Valid
Active ingredient
Pregabalim
Dosage form
Pregabalim
Strength
75mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Scilife Pharma
Applicant / LTR
SAP HEALTH LTD
Country of origin
PAKISTAN
Manufacturer location
57/58, Korangi Creek Industrial Park Korangi Creek, Karachi, Pakistan

Source: Food and Drugs Authority · fetched 2026-05-22 02:34:33 · updated 2026-10-20 04:00:05

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Pregabalin is a medication used to help manage nerve pain and certain types of seizures.

What it treats

  • nerve pain (neuropathic pain)
  • epilepsy (seizures)
  • generalized anxiety disorder

How it works

Pregabalin works by calming overactive nerves in the brain and body, which helps to reduce pain and prevent seizures.

Who it's for

Pregabalin is for adults dealing with nerve pain, seizures, or anxiety issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: pregabalim

Pregabalin is an anticonvulsant and analgesic agent, primarily used for the management of neuropathic pain, epilepsy, and generalized anxiety disorder. It is structurally related to the neurotransmitter gamma-aminobutyric acid (GABA), though it does not bind to GABA receptors. Pregabalin is indicated for various conditions involving nerve pain and seizure disorders.

Indications

  • Neuropathic pain associated with diabetic peripheral neuropathy
  • Postherpetic neuralgia
  • Fibromyalgia
  • Partial-onset seizures in adults with epilepsy
  • Generalized anxiety disorder

Dosage

Children: Refer to the BNF for Children for specific dosing information.

Adults: Refer to the BNF for specific dosing information.

Mechanism of action

Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This action inhibits excitatory neurotransmitter release, leading to a reduction in neuronal excitability and modulation of pain pathways.

Pharmacodynamics

Pregabalin exhibits analgesic and anticonvulsant properties. It is effective in reducing neuropathic pain by decreasing the release of several neurotransmitters, including glutamate, norepinephrine, and substance P. It has a rapid onset of action and its effects can be observed within a week of starting treatment.

Pharmacokinetics

Pregabalin is well absorbed after oral administration, with peak plasma concentrations typically reached within 1 hour. It has a bioavailability of approximately 90%, and food does not significantly affect its absorption. The drug is not extensively metabolized in the liver and is excreted unchanged in the urine. It has a half-life of about 6 hours, necessitating multiple daily doses for sustained effect.

Contra-indications

  • Hypersensitivity to pregabalin or any of its components
  • Severe renal impairment

Adverse effects

  • Dizziness
  • Somnolence
  • Dry mouth
  • Edema
  • Weight gain
  • Blurred vision
  • Cognitive dysfunction
  • Increased appetite
  • Constipation

Interactions

  • CNS depressants may enhance the sedative effects of pregabalin
  • Pregabalin may increase the risk of respiratory depression when used with opioids
  • Alcohol may increase adverse effects and should be used with caution

Precautions

  • Monitor for signs of misuse, abuse, or dependence
  • Caution in patients with a history of substance abuse
  • Assess renal function prior to initiation and adjust dose accordingly
  • Risk of suicidal thoughts or behavior has been observed

Pregnancy

Pregabalin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown reproductive toxicity.

Breast-feeding

Pregabalin is excreted in breast milk, and caution should be exercised when administering to breastfeeding women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Capsules
  • Oral solution

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.